On June 14, 2025, the 8th China Pharmaceutical Regulatory Science Conference, hosted by the China Association for Market Regulation, was grandly opened at the Beijing Convention Center. On the 15th, Zhou Xuehui, the Managing Director of Guangzhou Biaoji, as a representative of packaging material testing enterprises, gave a presentation at a sub forum.

With the core theme of "comprehensively deepening reform, fully promoting innovation, and high-quality development in the whole region - enabling the modernization of Chinese drug regulation with regulatory science", the conference gathered top decision-makers, academic scholars and industry elites in the field of drug regulation across the country: Xu Jinghe, member of the Party Leadership Group and deputy director of the State Drug Administration, Chen Runsheng, academician of the Chinese Academy of Sciences, president of pharmaceutical research of the Chinese Academy of Medical Sciences, Jiang Jiandong, academician of the Chinese Academy of Engineering, Zhao Junning, former deputy director of the State Food and Drug Administration, Zhou Le, deputy director of the Drug Administration Department of the State Food and Drug Administration, Liu Jihong, deputy director of the Department of Policies and Regulations, Shen Chuanyong, director of the Drug Evaluation Center of the State Food and Drug Administration, and other experts and scholars attended and made speeches.

Xu Jinghe, member of the Party Group and Deputy Director of the National Medical Products Administration, attended the opening ceremony and delivered a speech. He emphasized that the drug regulatory system should deeply implement the spirit of the Party, fully implement the "Opinions of the General Office of the State Council on Deepening the Reform of Drug and Medical Device Regulation to Promote the High quality Development of the Pharmaceutical Industry", continuously deepen the reform of the review and approval system, strengthen the quality supervision of the entire life cycle, and make greater contributions to protecting and promoting public health.

At the sub forum on "Policies and Technical Supervision of Innovative and Generic Drug Packaging" held on June 15th,Zhou Xuehui, Managing Director of Guangzhou Biaoji Packaging Equipment Co., Ltd., gave a special report on "Barrier Testing Technology and Instruments for Plastic Packaging Materials" on stage.

The report directly addresses the core pain point of drug safety: the barrier performance of packaging materials. General Manager Zhou Xuehui deeply analyzed the decisive role of barrier testing in ensuring the stability, effectiveness, and safety of drugs, and demonstrated the innovative achievements of the standard from multiple aspects: the independent core component - high-precision infrared sensor, the overall barrier testing solution for packaging containers, and case demonstrations of cutting-edge testing technologies.

Although drug packaging materials are small, they carry the first line of defense for drug safety. Minor defects in packaging materials may lead to drug failure or even deterioration, directly threatening the health of patients. The standardized technology system is the "technology sentinel" guarding this line of defense. Zhou Xuehui stated that as a national high-tech enterprise with 23 years of deep cultivation in the field of packaging testing, Guangzhou Biaojian has grown into a leading enterprise in the industry and is a national standard setter - the research and development unit of the national standard substance series for moisture, oxygen, and air permeability; National Certification - National Specialized and Innovative "Little Giant" Enterprise, National Intellectual Property Advantage Enterprise; Having CNAS/CMA dual certification third-party testing company; Our products cover core detection areas such as gas permeability and water vapor permeability, providing pharmaceutical companies with a full process quality control solution.

As a representative of packaging material testing enterprises at the conference, this is a recognition of the national bureau, China National Institute of Inspection, research association, and organizing committee for the standardized products and technical strength. Guangzhou Biaoji will continue to forge ahead and provide scientific solutions for the quality control of pharmaceutical packaging materials.

Drug safety begins with packaging materials; Packaging material safety is achieved through testing

In the future, Guangzhou Biaoji will continue to use innovation as the engine and precision testing technology as the cornerstone, deeply integrating into the magnificent journey of modernization of China's drug regulation and high-quality development of the industry. We are committed to working together with regulatory agencies, research partners, and industry colleagues to build an unbreakable technological defense line for drug safety, and contribute irreplaceable standardized strength to the high-quality development of China's pharmaceutical industry!